“Finding a cure for cancer is absolutely contraindicated by the profits of the cancer industry’s chemotherapy, radiation and surgery cash trough.” — John Diamond, M.D.
“We have a multi-billion dollar industry that is killing people, right and left, just for financial gain. Their idea of research is to see whether two doses of this poison is better than three doses of that poison.” —Glen Warner, M.D., oncologist
“Most cancer patients in this country die of chemotherapy… Chemotherapy does not eliminate breast, colon or lung cancers. This fact has been documented for over a decade. Yet doctors still use chemotherapy for these tumors…Women with breast cancer are likely to die faster with chemo than without it.” — Alan Levin, M.D.
“…chemotherapy’s success record is dismal. It can achieve remissions in about 7% of all human cancers; for an additional 15% of cases, survival can be “prolonged” beyond the point at which death would be expected without treatment. This type of survival is not the same as a cure or even restored quality of life…Keep in mind that the 5 year mark is still used as the official guideline for “cure” by mainstream oncologists. Statistically, the 5 year cure makes chemotherapy look good for certain kinds of cancer, but when you follow cancer patients beyond 5 years, the reality often shifts in a dramatic way.” — John Diamond, M.D.
“Success of most chemotherapy is appalling…There is no scientific evidence for its ability to extend in any appreciable way the lives of patients suffering from the most common organic cancer… chemotherapy for malignancies too advanced for surgery which accounts for 80% of all cancers is a scientific wasteland.” — Dr. Ulrich Abel, 1990
“As a chemist trained to interpret data, it is incomprehensible to me that physicians can ignore the clear evidence that chemotherapy does much, much more harm than good.” — Alan Nixon, Ph.D., Past President, American Chemical Society.
“In the end, there is no proof that chemotherapy in the vast majority of cases actually extends life and this is the GREAT LIE about chemotherapy, that somehow there is a correlation between shrinking a tumor and extending the life of the patient.” — Dr. Ralph Moss, Ph.D.
“Children who are successfully treated for Hodgkin’s disease are 18 times more likely later to develop secondary malignant tumors. Girls face a 35 per cent chance of developing breast cancer by the time they are 40—which is 75 times greater than the average. The risk of leukemia increased markedly four years after the ending of successful treatment, and reached a plateau after 14 years, but the risk of developing solid tumors remained high and approached 30 percent at 30 years.” — New England Journal of Medicine, March 21, 1996
“Many oncologists would not take chemotherapy themselves if they had cancer. Even though toxic drugs often do affect a response, a partial or complete shrinkage of the tumor, this reduction does not prolong expected survival. Sometimes, in fact, the cancer returns more aggressively than before, since the chemo fosters the growth of resistant cell lines. Besides, the chemo has severely damaged the body’s own defenses, the immune system and often the kidneys as well as the liver.” — Cancer Chronicles, December, 1990
“A study of over 10,000 patients shows clearly that chemo’s supposedly strong track record with Hodgkin’s disease (lymphoma) is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy.” — John Diamond, M.D.
From John Robbin’s book RECLAIMING OUR HEALTH: EXPLODING THE MEDICAL MYTH AND EMBRACING THE SOURCE OF TRUE HEALING:
Conclusive evidence (majority of cancers) that chemotherapy has any positive influence on survival or quality of life – none.
Percentage of oncologists who said if they had cancer they would not participate in chemotherapy trial due to its “ineffectiveness and its unacceptable toxicity” – 75%
Percentage of people with cancer in the U.S. who receive chemotherapy – 75%
Studies show that women taking tamoxifen after surviving breast cancer then have a high propensity to develop endometrial cancer. The NCI and Zeneca Pharmaceuticals, which makes the drug, aggressively lobbied State of California regulators to keep them from adding tamoxifen to their list of carcinogens. Zeneca is one of the sponsors of Breast Cancer Awareness Month.
|Studies show that women taking tamoxifen after surviving breast cancer then have a high propensity to develop endometrial cancer. The NCI and Zeneca Pharmaceuticals, which makes the drug, aggressively lobbied State of California regulators to keep them from adding tamoxifen to their list of carcinogens. Zeneca is one of the sponsors of Breast Cancer Awareness Month.